Form D · Other
Vaginal Biome Science, Inc.
Eugene, OR · CIK 0001937933
Offering snapshot reported Jul 14, 2022 · SEC filing
- Reported sold
- $3.06M Offering amount: $3.06M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2022 | Initial | $3,056,339 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-452298
Source: Form D, filed Jul 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Guseinov | Director |
| Michael Harrison Jones | Director |
| Jane David Miller | Director |
| Wendy Orlow Strgar | Director, Executive, Promoter |
| Luke Vincent Strgar | Director |
| Tom Zelenovic | Director |
Issuer details
Industry: Other (See others in industry)
Address:
207 West 5 Th Ave
Eugene, OR, 97401
Eugene, OR, 97401